Skip to content
ppharmaranks
Menu
Class IIOngoing

Vial Label: 8.4% Sodium Bicarbonate Injection recall

FDA recall D-0591-2025 · initiated Aug 4, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Aug 27, 2025How we research

PFIZER INC recalled Vial Label: 8.4% Sodium Bicarbonate Injection in Aug 2025 — an FDA Class II recall (D-0591-2025) because Lack of Assurance of Sterility.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility.

Sterility could not be assured

The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: LH2671, Exp. 11/30/2026

Quantity recalled: 15,750 vials

Details

Product
Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.
Recalling company
Pfizer Inc
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Aug 4, 2025
FDA report date
Aug 27, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Vial Label: 8.4% Sodium Bicarbonate Injection recalled?
PFIZER INC recalled Vial Label: 8.4% Sodium Bicarbonate Injection in Aug 2025 — an FDA Class II recall (D-0591-2025) because Lack of Assurance of Sterility. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Vial Label: 8.4% Sodium Bicarbonate Injection recalled?
Per the FDA enforcement record, the reason for recall D-0591-2025 was: Lack of Assurance of Sterility.
Is a recalled Vial Label: 8.4% Sodium Bicarbonate Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Vial Label: 8.4% Sodium Bicarbonate Injection are affected?
Distributed: U.S. Nationwide. The recall covers these lots — Lot #: LH2671, Exp. 11/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0591-2025.

Source: openFDA Drug Enforcement record D-0591-2025

← All drug recalls